Clinical Trials Browser

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Anus Neoplasms

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

Oropharyngeal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Prostatic Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular, Cholangiocarcinoma

Salivary Gland Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

Prostatic Neoplasms

Brain Neoplasms, Medulloblastoma

Prostatic Neoplasms

Neoplasm Metastasis

Lymphoma, Large B-Cell, Diffuse

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

Sarcoma, Ewing

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Astrocytoma, Glioblastoma, Oligodendroglioma

Esophageal Neoplasms

Prostatic Neoplasms

Lymphoma, Mantle-Cell

Prostate Adenocarcinoma

Skin Diseases, Skin Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Prostatic Neoplasms

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Endometriosis, Endometrial Neoplasms

Oligometastatic Prostate Carcinoma

Neoplasm Metastasis, Hematologic Neoplasms

Mycosis Fungoides

Glioblastoma, Gliosarcoma

Pancreatic Neoplasms

Mouth Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Vulvar Neoplasms

Prostatic Neoplasms

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Multiple Myeloma

Esophageal Cancer TNM Staging Primary Tumor (T) T4

Clinical Trials

PNOC023

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

(NeoScorch HN)

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

DEBRA

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

MelPORT

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

BEAR

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

DIVINE

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

IS-free Treg HaploHCT

Hypofractionation (Radiation) Trial for Multiple Myeloma

Establishing Best Treatment Strategy for T4 Esophageal Cancer